Tagged with research,

Puerto Rico José F Rodríguez Orengo is the CEO and Chief Scientific Officer at the Fundación de Investigación (FDI) Clinical Trials, Puerto Rico’s main clinical research centre. In this interview, Rodríguez Orengo highlights his priorities of extending the capabilities and also becoming active in the space of public health. He also discusses…

China Dr Dafang Zhong, director of Shanghai Center for Drug Metabolism and Pharmacokinetics Research at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, shares his professional career within the DMPK space, as well as the important work that the Center has done in contributing to the growth and development…

Sweden Anders Ekblom is the former EVP Global Medicines Development AstraZeneca and CEO of AstraZeneca AB Sweden and is currently the Vice Chairman of the Board of LEO Pharma A/S. Additionally, he also occupies board positions on many biotech companies (Elypta, Alligator Bioscience AB, Mereo Biopharma Group Plc, AnaMar Medical AB).…

Sweden Anders Blanck, director general of LIF, Sweden’s association representing the research-based pharmaceutical industry, breaks down the ins and outs of the country’s regionalized healthcare system and the drivers of the Swedish pharmaceutical market. He then delves into the reforms Sweden needs to undertake for its healthcare system to adapt to…

France Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the French clinical trials environment and stresses the importance of France in PPD’s overall operations. She also explains how the contract research organization is catering to the needs of…

Sweden Anna Nilsson Vindefjärd of Research!Sweden, explains the critical role of the foundation as a neutral actor in Sweden’s healthcare ecosystem, gathering prominent individuals from politics, regulators, academia, patient groups, healthcare and industry who agree on one thing: the need to make medical research and innovation a national priority.   As…

Taiwan Rita Huang, dean of the Office of Research and Development and the director of the TMU Research Center for Cell Therapy and Regeneration Medicine highlights the center’s unique capabilities and its innovative research projects within the emerging space of stem cell treatments. She goes on to give her insights on…

Egypt Ashraf Elkhouly, executive director of the Egyptian Society for Pharmaceutical Research, discusses how recent healthcare reforms will help to attract more investment to Egypt and the importance of public-private partnerships for improving the country’s healthcare system.   In collaboration with the government, we started to look into possibilities on how…

China Amidst the sea of Big Pharma executives jumping ship to start highly regarded and attention-grabbing biotech companies, bolstered by the huge influx of capital, the opening of stock exchanges in first Hong Kong and subsequently Shanghai to pre-profit biotech companies that meet certain criteria, as well as the reformation and…

France Faten Hidri, VP for Higher Education & Research in the Paris Region (Ile de France), discusses the vital role of academic research and the life sciences in her region and ongoing collaboration with other European stakeholders.   While the Paris region is the European leader in terms of patent filings,…

France Bertrand Sohier, VP and general manager business and administration of Parexel France discusses the latest trends impacting the clinical research environment of the country, gives insight on the strategies the company utilizes to differentiate itself from competitors, and shares the importance of keeping a patient-focused mentality at the core of…

France Jean-Marc Grognet, general manager of Genopole, France’s leading biotechnology cluster, explains the organization’s unique triangular structure with the corner points of the cluster being higher education, research, and industry. Grognet goes on to elaborate on the cluster’s extensive scientific offering and his ambitions to build a collaborative network of life…